aid: astrazeneca
url: https://raw.githubusercontent.com/api-evangelist/astrazeneca/refs/heads/main/apis.yml
name: AstraZeneca
type: Index
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/apis-json-logo.jpg
tags:
  - Pharmaceutical
  - Biotechnology
  - Healthcare
description: >-
  AstraZeneca is a British-Swedish multinational pharmaceutical and
  biotechnology company focused on oncology, cardiovascular, renal,
  metabolism, and respiratory therapies. AstraZeneca does not publish a
  general developer portal or commercial public APIs; technology integration
  is delivered through enterprise partner programs, clinical trial data
  portals such as clinicaltrials.gov and the Vivli platform, and EDI/x12
  channels used by distributors and pharmacy benefit managers.
created: '2026-05-05'
modified: '2026-05-16'
specificationVersion: '0.19'
apis: []
common:
  - type: DomainSecurity
    url: security/astrazeneca-domain-security.yml
  - type: GitHubOrganization
    url: https://github.com/AstraZeneca
  - type: LinkedIn
    url: https://www.linkedin.com/company/astrazeneca
  - type: Website
    url: https://www.astrazeneca.com/
  - type: ClinicalTrials
    url: https://www.astrazenecaclinicaltrials.com/
  - type: DataSharing
    url: https://www.astrazenecaclinicaltrials.com/transparency/data-sharing/
  - type: Partnerships
    url: https://www.astrazeneca.com/partnerships.html
  - type: Suppliers
    url: https://www.astrazeneca.com/suppliers.html
  - type: PrivacyPolicy
    url: https://www.astrazeneca.com/legal/integrated-privacy-notice.html
  - type: TermsOfService
    url: https://www.astrazeneca.com/legal/terms-of-use.html
  - type: Contact
    url: https://www.astrazeneca.com/contact-us.html
  - type: Features
    data:
      - name: Clinical Trial Information
        description: Clinical trial registrations and results are publicly accessible via clinicaltrials.gov, the EU Clinical Trials Register, and AstraZeneca's own trial site.
      - name: Patient-Level Data Sharing
        description: Anonymized patient-level clinical trial data is made available to qualified researchers through the Vivli platform.
      - name: Medical Information Portal
        description: Healthcare professionals can request product and safety information via country-specific medical information sites.
      - name: Distributor and Wholesaler EDI
        description: Drug ordering, returns, chargebacks, and shipment notifications are exchanged with distributors via standardized x12 EDI transactions.
      - name: Pharmacovigilance Submissions
        description: Adverse-event reports are received via regulatory channels (E2B, FAERS) rather than a public API.
  - type: UseCases
    data:
      - name: Clinical Research Data Discovery
        description: Find and link AstraZeneca-sponsored studies into clinical research and evidence-generation platforms.
      - name: Pharma Supply Chain Integration
        description: Distributors integrate order, shipment, and chargeback flows with AstraZeneca's commercial supply chain via EDI.
      - name: Medical Affairs Engagement
        description: HCPs and medical-information vendors retrieve dosing, contraindication, and interaction information for clinical decision support.
      - name: Real-World Evidence Studies
        description: Researchers use the Vivli platform to combine AstraZeneca trial data with external real-world evidence sources.
  - type: Compliance
    data:
      - name: HIPAA
        description: U.S. operations involving protected health information are subject to HIPAA Privacy and Security Rules.
      - name: GDPR
        description: European patient and trial data handling is governed by the EU General Data Protection Regulation.
      - name: FDA 21 CFR Part 11
        description: Electronic records and signatures supporting AstraZeneca's regulated processes follow FDA 21 CFR Part 11 requirements.
      - name: GxP (GMP / GCP / GLP / GVP)
        description: Manufacturing, clinical, lab, and pharmacovigilance practices follow applicable Good Practice standards.
      - name: ICH E2B
        description: Adverse-event reporting follows the ICH E2B(R3) standard for individual case safety reports.
plansReconciled: false
rateLimitsReconciled: false
finopsReconciled: false
position: Consuming
maintainers:
  - FN: Kin Lane
    email: kin@apievangelist.com